Search

everythinglearnresearchcommunity

for

Search:↓

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

New engineering methods show promise for regenerating hair follicles using stem cells and advanced technologies.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

A silk fibroin hydrogel boosts wound healing and hair growth by increasing collagen and hair follicles.

AI improves aesthetic medicine but faces challenges like biases and privacy issues that need addressing for successful integration.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

APA is a promising new compound for repairing damaged hair, outperforming Olaplex® in strength and elasticity.

Rhus semialata gall extract and Penta-O-Galloyl-β-D-Glucose may effectively reduce hair loss.

New non-invasive techniques can improve diagnosis and treatment of scalp and hair diseases.

SHED-CM can reduce hair graying and protect against damage from X-rays.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Exosomes could improve skin care, but more research is needed to confirm their safety and effectiveness.

Skin, hair, and nail changes can help detect eating disorders early.

Bovine milk-derived exosomes may improve skin, hair, gut, brain, and bone health.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Cell growth improved the strength of 3D bioprinted structures.

The tonic boosts hair growth and fights dandruff using natural electric energy.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

K18® and Olaplex® both effectively repair bleached hair, improving its strength, smoothness, and overall health.

Plant extracts may help prevent or reverse hair graying.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Dermal factors are crucial in regulating melanin production in skin.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Excessive blue light harms eye cells and disrupts sleep patterns.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.